David Leduc
David Leduc publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Global Cancer Incidence and Screening.
- World rank
- #5,902,994 of 7,710,434 ranked researchers
- Rank in United States
- #1,448,057 of 1,627,098
- Works
- 17
- Citations
- 25
- Citations per work
- 1.5
What does David Leduc research?
David Leduc's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (7%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences953.4%
- Medicine953.4%
- Everything else528.8%
- Social Sciences211.1%
- Life Sciences16.7%
- 1Pulmonary and Respiratory Medicine31% of their works
- 2Oncology16% of their works
- 3Economics and Econometrics7% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Cancer Research7% of their works
- 6Clinical Psychology4% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Radiomics and Machine Learning in Medical Imaging
- Agriculture and Rural Development Research
Which keywords describe David Leduc's research?
The keywords of their largest research topics: Targeted Therapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer, Cancer Incidence, Cost of Care and Financial Toxicity.
- Livestock Farming
- PD-1 and PD-L1
- Medical Imaging
- Cancer Genomics
- Financial Toxicity
- Cancer Incidence
- CT Screening
- ALK Inhibitors
- Targeted Therapy
- EGFR Mutations
- Lung Cancer
- Cost of Care
- Mortality Rates
- Immune Checkpoint Blockade
- Mutational Signatures
- Radiomics
- Sustainability
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Targeted Therapy82 topics
- ALK Inhibitors61 topic
- EGFR Mutations61 topic
- CT Screening41 topic
- Lung Cancer41 topic
- Cancer Incidence31 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
- Mortality Rates31 topic
- Cancer Genomics21 topic
- Immune Checkpoint Blockade21 topic
- Medical Imaging21 topic
- Mutational Signatures21 topic
- PD-1 and PD-L121 topic
- Radiomics21 topic
- Livestock Farming11 topic
- Sustainability11 topic
Where does David Leduc work?
David Leduc's main affiliation in the publication record is Go2 for Lung Cancer, United States.
How many publications and citations does David Leduc have?
OpenAlex counts 17 works and 25 citations for David Leduc, an h-index of 3, ranking #5,902,994 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Leduc. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.